Ferrell, Jessica M.

Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy

Chiang, J. Y. L., & Ferrell, J. M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Drug Transport and Resistance MechanismsCholesterol and Lipid Metabolism

Cited by 580

Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism

Pathak, P., Xie, C., Nichols, R. G., Ferrell, J. M., Boehme, S., Krausz, K. W., Patterson, A. D., Gonzalez, F. J., & Chiang, J. Y. L. (2018) · Hepatology

Drug Transport and Resistance MechanismsGut microbiota and health

Cited by 567

Understanding bile acid signaling in diabetes: From pathophysiology to therapeutic targets

Ferrell, J. M., & Chiang, J. Y. L. (2019) · Diabetes & Metabolism Journal

Drug Transport and Resistance MechanismsGut microbiota and health

Cited by 139

Cholesterol 7α-hydroxylase-deficient mice are protected from high-fat/high-cholesterol diet-induced metabolic disorders

Ferrell, J. M., Boehme, S., Li, F., & Chiang, J. Y. L. (2016) · Journal of Lipid Research

Cholesterol and Lipid MetabolismDrug Transport and Resistance Mechanisms

Cited by 112

Deficiency of Both Farnesoid X Receptor and Takeda G Protein–Coupled Receptor 5 Exacerbated Liver Fibrosis in Mice

Ferrell, J. M., Pathak, P., Boehme, S., Gilliland, T., & Chiang, J. Y. L. (2019) · Hepatology

Drug Transport and Resistance MechanismsLiver physiology and pathology

Cited by 65